Do patients with oxyphilic cell papillary thyroid carcinoma have a poor prognosis? Analysis of the surveillance, epidemiology, and end results database 2004-2013 with propensity score matching-Reference-Cited by-同舟云学术

Do patients with oxyphilic cell papillary thyroid carcinoma have a poor prognosis? Analysis of the surveillance, epidemiology, and end results database 2004-2013 with propensity score matching

Published:2017-08-18 Issue:44 Volume:8 Page:77075-77085
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Chunping¹,Zhao Qiuyang¹,Zeng Wen²,Chen Chen¹,Ming Jie¹,Wang Shuntao¹,Xiong Yiquan¹,Zhang Chao³,Chen Tianwen⁴,Liu Zeming¹,Huang Tao¹

Affiliation:

1. Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

2. Department of Ophthalmology, Zhongnan Hospital, Wuhan University, Wuhan, China

3. Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

4. Department of Breast and Thyroid Surgery, Affiliated Nanshan Hospital, Guangdong Medical University, Shenzhen, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comportamiento clínico de la variante oncocítica del cáncer papilar de tiroides: comparación de su evolución frente al cáncer papilar, variantes clásica y de células altas;Revista Española de Medicina Nuclear e Imagen Molecular;2023-03

2. Clinical behaviour of papillary thyroid cancer oncocytic variant: stage-matched comparison versus classical and tall cell variant papillary thyroid cancer;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2023-03

3. Hürthle-cell neoplasms of the thyroid: An algorithmic approach to pathologic diagnosis in light of molecular advances;Seminars in Diagnostic Pathology;2020-09

4. LINC01410/miR-3619-5p/FOXM1Feedback Loop Regulates Papillary Thyroid Carcinoma Cell Proliferation and Apoptosis;Cancer Biotherapy and Radiopharmaceuticals;2019-11-01

5. Long-term outcome of rare oncocytic papillary (Hürthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy;European Journal of Nuclear Medicine and Molecular Imaging;2019-08-13